進行性心不全と移植性心臓病のマッチで満たされていないトレーニングポジションの増加率
Jason Silvestre1, Ahmed Brgdar2, Jay Chen2
1Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
The American journal of cardiology
|September 4, 2025
まとめ
先進心不全と移植心臓学 (AHFTC) 奨学金研修への関心は低下しており,心不全の専門家の需要が増加しているにもかかわらず,空き職が著しく増加しています.
科学分野:
- 心臓病科
- 医学教育
- 移植 手術
背景:
- 先進心不全と移植心臓病 (AHFTC) は,複雑な心不全の管理と先進的な治療法の実施に不可欠です.
- 臨床的需要が増加しているにもかかわらず AHFTCの奨学金プログラムへの関心が 減少している傾向があります
研究 の 目的:
- 2020年から2025年までのAHFTCフェローシップの申請者,研修職,マッチ率,未充填職の動向を分析する.
- 訓練能力とAHFTCへの応募者の関心のギャップを特定する.
主な方法:
- 2020年から2025年のAHFTCフェローシップマッチデータの全国的横断分析.
- 応募者数,研修職,マッチ率,空いた職の評価
- タイムトレンドを評価するための線形回帰分析
主要な成果:
- AHFTCの研修職数は10%増加し,応募者は2020年から2025年の間に24%減少した.
- 求人者対職の比率は大幅に低下し,未充填の職は30%から52%に増加しました.
- 応募者が減ったにもかかわらず,最初の選択のプログラムでマッチングの割合は増加しました.
結論:
- AHFTCの研修能力と応募者の関心は相違しており,空き職が増えている.
- 心不全の治療のための将来の労働力を確保するためにAHFTC訓練への関心を刺激する緊急の戦略が必要です.
- この調査結果は,AHFTCのサブスペシャリティを維持し,成長させるための積極的な措置の必要性を強調しています.
関連する概念動画
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Imbalances in Cardiac Output
1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure II: Pathophysiology
33
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
33


